These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2219313)

  • 1. Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
    Hancock WW; Sablinski T; Milford EL; Tilney NL; Atkins RC; Kupiec-Weglinski JW
    Transplant Proc; 1990 Oct; 22(5):2115-6. PubMed ID: 2219313
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 5. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
    Sablinski T; Hancock WW; Schmidbauer G; Milford EL; Kupiec-Weglinski JW
    Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4.
    Hancock WW; Sayegh MH; Carpenter CB
    Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
    J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
    Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 15. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral immunization with allogeneic splenocytes inhibits development of accelerated but not acute rejection of cardiac grafts: analysis of intragraft effector mechanisms.
    Hancock WW; Sayegh MH; Zhang ZJ; Kwok CA; Weiner HL; Carpenter CB
    Transplant Proc; 1992 Feb; 24(1):250-1. PubMed ID: 1539269
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
    Paul LC; Davidoff A; Benediktsson H; Issekutz TB
    Transplantation; 1993 May; 55(5):1196-9. PubMed ID: 8497903
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.